Abstract: A process for oxidative dehydrogenation of a hydrocarbon to produce an olefin and water may include contacting, in a fluidized bed, the hydrocarbon with a particulate material, which may include at least one oxygen transfer agent (OTA) and at least one fluidization enhancing additive. During at least a portion of contacting the hydrocarbon with the particulate material, the fluidized bed may be at a temperature at or above a melting point of one or more materials of the oxygen transfer agent. Further, during at least a portion of contacting the hydrocarbon with the particulate material, a surface of at least a portion of the OTA may comprise a molten layer. The fluidization enhancing additive may not undergo reduction in the fluidized bed during contacting the hydrocarbon with the particulate material and may be present in an amount that maintains sufficient fluidization of the particulate material.

Abstract: The present invention provides methods for isolating an active polypeptide or immunoconjugate by purification of a solution containing both the active polypeptide or immunoconjugate and an acidic variant thereof, such as a deamidated variant, using anion exchange chromatography. The present invention also provides compositions, formulations, and unit dosage forms comprising the purified polypeptide or immunoconjugate.

Abstract: The present invention provides methods for isolating an active polypeptide or immunoconjugate by purification of a solution containing both the active polypeptide or immunoconjugate and an acidic variant thereof, such as a deamidated variant, using anion exchange chromatography. The present invention also provides compositions, formulations, and unit dosage forms comprising the purified polypeptide or immunoconjugate.

Abstract: A system for oxidative conversion of a mixed hydrocarbon feed stream to a product stream containing at least one olefin is provided. The system includes a plurality of reactors each capable of oxidatively dehydrogenating at least a portion of a hydrocarbon in the mixed hydrocarbon feed, and each reactor able to operate at different set of reaction conditions from other reactors in the plurality of reactors. All of the reactors use the same oxygen transfer agent to produce at least one olefin. In some embodiments, at least one reactor is optimized to oxidatively couple methane to produce ethylene, while other reactors are optimized to oxidatively dehydrogenate ethane to ethylene or to oxidatively dehydrogenate propane to ethylene and/or propylene. All of the reactors feed into a single regeneration unit for the oxygen transfer agent. A method of oxidatively converting the mixed hydrocarbon feed to an olefin is also provided.

Abstract: Aspects of the invention relate to producing olefins and other products by oxidative dehydrogenation cracking of a hydrocarbon feed. In one embodiment, the method includes oxidative cracking a hydrocarbon feed comprised of plastic waste. Methods of the present invention employ dual functional catalyst comprising solid acids and metal oxides, which are capable of selectively oxidizing hydrogen to water rather than combustion of the hydrocarbon feeds or products. Additional aspects of the invention demonstrate catalyst synthetic methods for encapsulating metal oxides in the internal channels and cages of solid acids, thereby improving the selective oxidation of hydrogen to water and decreasing feed and product oxidation. The re-oxidation of the thus reduced metal oxide transfer agents supplies heat to drive the endothermic cracking of the feed.

Abstract: The present invention provides methods for isolating an active polypeptide or immunoconjugate by purification of a solution containing both the active polypeptide or immunoconjugate and an acidic variant thereof, such as a deamidated variant, using anion exchange chromatography. The present invention also provides compositions, formulations, and unit dosage forms comprising the purified polypeptide or immunoconjugate.

Abstract: The present invention provides methods for isolating an active polypeptide or immunoconjugate by purification of a solution containing both the active polypeptide or immunoconjugate and an acidic variant thereof, such as a deamidated variant, using anion exchange chromatography. The present invention also provides compositions, formulations, and unit dosage forms comprising the purified polypeptide or immunoconjugate.

Abstract: The present invention provides methods for isolating an active polypeptide or immunoconjugate by purification of a solution containing both the active polypeptide or immunoconjugate and an acidic variant thereof, such as a deamidated variant, using anion exchange chromatography. The present invention also provides compositions, formulations, and unit dosage forms comprising the purified polypeptide or immunoconjugate.

Abstract: The present invention provides methods for isolating an active polypeptide or immunoconjugate by purification of a solution containing both the active polypeptide or immunoconjugate and an acidic variant thereof, such as a deamidated variant, using anion exchange chromatography. The present invention also provides compositions, formulations, and unit dosage forms comprising the purified polypeptide or immunoconjugate.

Abstract: The present invention provides methods for isolating an active polypeptide or immunoconjugate by purification of a solution containing both the active polypeptide or immunoconjugate and an acidic variant thereof, such as a deamidated variant, using anion exchange chromatography. The present invention also provides compositions, formulations, and unit dosage forms comprising the purified polypeptide or immunoconjugate.

Abstract: The present invention provides methods for isolating an active polypeptide or immunoconjugate by purification of a solution containing both the active polypeptide or immunoconjugate and an acidic variant thereof, such as a deamidated variant, using anion exchange chromatography.

Abstract: The present invention provides methods for isolating an active polypeptide or immunoconjugate by purification of a solution containing both the active polypeptide or immunoconjugate and an acidic variant thereof, such as a deamidated variant, using anion exchange chromatography.